Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis (original) (raw)

Cystic Fibrosis: Biology and Therapeutics

vishal kumar vishwakarma

Chronic Lung Diseases, 2020

View PDFchevron_right

Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011

Ganesh Raghu

European Respiratory Journal, 2011

View PDFchevron_right

Environmental, Inhaled and Ingested Causes of Pulmonary Fibrosis

Nasreen Khalil

Toxicologic Pathology, 2007

View PDFchevron_right

Cystic fibrosis

Alexandra Quittner

Nature Reviews Disease Primers, 2015

View PDFchevron_right

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis

Carolina Garcia de Alba Rivas

The International Journal of Biochemistry & Cell Biology, 2008

View PDFchevron_right

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis

Omkar Desai

Frontiers in Medicine

View PDFchevron_right

Post-COVID-19 Pulmonary Fibrosis

Noemi Sarabia

Cureus, 2022

View PDFchevron_right

High-dose acetylcysteine in idiopathic pulmonary fibrosis

Franco Corvatta

New England Journal of Medicine, 2008

View PDFchevron_right

[Diffuse pulmonary fibrosis in children]

Macdex Mutema

Pediatriia, 1983

View PDFchevron_right

Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?

Stefania Cerri

Critical Care, 2018

View PDFchevron_right

An experimental mouse model of lung fibrosis

Hani Hafez

International Journal of Cancer and Biomedical Research, 2020

View PDFchevron_right

Cardiac manifestations of idiopathic pulmonary fibrosis

Abhinav Agrawal

Intractable & Rare Diseases Research, 2016

View PDFchevron_right

Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders

Federica Lorenzi

Advanced Drug Delivery Reviews, 2021

View PDFchevron_right

Chronic inflammation and asthma

Jenna Macciochi

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010

View PDFchevron_right

A Critically Appraised Topic: Is There an Effective Post-Covid Pulmonary Fibrosis Treatment

Eman Almaghaslah

Zenodo (CERN European Organization for Nuclear Research), 2023

View PDFchevron_right

2013 Respiratory Research inflammation depression pulmonary function

Shwe Nyunt

View PDFchevron_right

Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19

Akio Niimi

Internal Medicine, 2022

View PDFchevron_right

Update in Cystic Fibrosis 2011

Susanna McColley

American Journal of Respiratory and Critical Care Medicine, 2012

View PDFchevron_right

Smoking-related interstitial lung disease

Stefania Cerri

European Respiratory Society eBooks, 2011

View PDFchevron_right

Severity of Illness and Outcome in Patients With End-Stage Idiopathic Pulmonary Fibrosis Requiring Mechanical Ventilation

Annarita Vestri

CHEST Journal, 2010

View PDFchevron_right

Global Alliance against Chronic Respiratory Diseases

ronald dahl

Allergy, 2007

View PDFchevron_right

Imipenem/Cilastatin in Acute Pulmonary Exacerbations of Cystic Fibrosis

Katie Lin

Clinical Infectious Diseases, 1985

View PDFchevron_right

Study of interstitial lung diseases at a tertiary care center

RAMAKRISHNA RACHAKONDA

IP Indian Journal of Immunology and Respiratory Medicine, 2018

View PDFchevron_right

Chronic Obstructive Pulmonary Disease (COPD)

Bhairav Vaibhav

American Journal of Respiratory and Critical Care Medicine, 1998

View PDFchevron_right

Manual Therapy as an Alternative Treatment Option for Idiopathic Pulmonary Fibrosis: A Case Report

Ishan Perera

Curēus, 2024

View PDFchevron_right